HAEMONETICS CORP shareholders Q3 2023

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
GOLDMAN SACHS GROUP INC 166,859$14,947,2300.00%
Ensign Peak Advisors, Inc 14,351$1,285,5630.00%
ProShare Advisors LLC 9,256$829,1530.00%
Raleigh Capital Management Inc. 74$6,6290.00%
ALPS ADVISORS INC 3,720$333,2380.00%
THRIVENT FINANCIAL FOR LUTHERANS 12,698$1,1370.00%
TD ASSET MANAGEMENT INC 23,600$2,114,0880.00%
Quarry LP 157$14,0640.00%
D. E. Shaw & Co., Inc. 29,408$2,634,3690.00%
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 14,315$1,282,3380.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 60,991$5,463,5740.00%
Legal & General Group Plc 81,007$7,256,6060.00%
Clearstead Trust, LLC 100$8,9580.00%
BARCLAYS PLC 37,596$3,3670.00%
BALDWIN BROTHERS LLC/MA 215$19,2600.00%
Hexagon Capital Partners LLC 73$6,5390.00%
Aspire Private Capital, LLC 75$6,7180.00%
Lindbrook Capital, LLC 247$22,1260.00%
AMERICAN CENTURY COMPANIES INC 27,308$2,446,2510.00%
Verition Fund Management LLC 2,380$213,2000.00%
External links

This page lists HAEMONETICS CORP's shareholders in Q3 2023. To view HAEMONETICS CORP's shareholder history, click here.